Arete Wealth Advisors, LLC Astrazeneca PLC Transaction History

Arete Wealth Advisors, LLC

$1.17 Billion
Q3 2024

A detailed history of Arete Wealth Advisors, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Arete Wealth Advisors, LLC holds 4,274 shares of AZN stock, worth $270,116. This represents 0.03% of its overall portfolio holdings.

Number of Shares

4,274

Previous 4,274 -0.0%

Holding current value

$270,116

Previous $333,000 -0.0%

% of portfolio

0.03%

Previous 0.03%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$76.67 - $87.62 $563,217 - $643,656	-7,346 Reduced 63.22%	4,274 $333,000
Q2 2024 Aug 13, 2024	BUY	$66.81 - $80.83 $42,090 - $50,922	630 Added 5.73%	11,620 $906,000
Q1 2024 May 15, 2024	SELL	$61.03 - $69.57 $7,079 - $8,070	-116 Reduced 1.04%	10,990 $744,000
Q4 2023 Feb 14, 2024	BUY	$61.89 - $69.28 $18,938 - $21,199	306 Added 2.83%	11,106 $747,000
Q3 2023 Oct 30, 2023	BUY	$64.85 - $71.7 $19,390 - $21,438	299 Added 2.85%	10,800 $731,000
Q2 2023 Aug 09, 2023	SELL	$69.91 - $75.81 $10,346 - $11,219	-148 Reduced 1.39%	10,501 $752,000
Q1 2023 May 01, 2023	SELL	$63.15 - $71.6 $99,334 - $112,626	-1,573 Reduced 12.87%	10,649 $739,000
Q4 2022 Feb 06, 2023	BUY	$54.21 - $70.44 $67,816 - $88,120	1,251 Added 11.4%	12,222 $828,000
Q3 2022 Nov 07, 2022	BUY	$53.02 - $135.75 $581,682 - $1.49 Million	10,971 New	10,971 $602,000
Q2 2022 Aug 15, 2022	SELL	$59.26 - $71.14 $353,485 - $424,350	-5,965 Closed	0 $0
Q1 2022 May 06, 2022	SELL	$55.72 - $67.12 $11,255 - $13,558	-202 Reduced 3.28%	5,965 $396,000
Q4 2021 Feb 07, 2022	BUY	$54.02 - $63.83 $333,141 - $393,639	6,167 New	6,167 $359,000
Q4 2020 Feb 08, 2021	SELL	$48.52 - $58.02 $296,602 - $354,676	-6,113 Closed	0 $0
Q3 2020 Nov 09, 2020	SELL	$53.07 - $61.1 $496,788 - $571,957	-9,361 Reduced 60.5%	6,113 $331,000
Q2 2020 Aug 11, 2020	BUY	$43.1 - $55.31 $428,586 - $550,002	9,944 Added 179.82%	15,474 $818,000
Q1 2020 May 14, 2020	BUY	$37.79 - $51.33 $1,549 - $2,104	41 Added 0.75%	5,530 $247,000
Q4 2019 Feb 14, 2020	SELL	$42.46 - $50.46 $3,396 - $4,036	-80 Reduced 1.44%	5,489 $274,000
Q3 2019 Nov 13, 2019	BUY	$40.12 - $45.47 $223,428 - $253,222	5,569 New	5,569 $248,000

Others Institutions Holding AZN

# of Institutions

1,360

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $196B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Arete Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Arete Wealth Advisors, LLC with notifications on news.

Account

Arete Wealth Advisors, LLC Astrazeneca PLC Transaction History